Lixiana
edoxaban
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
What Lixiana is and what it is used for
What you need to know before you take Lixiana
How to take Lixiana
Possible side effects
How to store Lixiana
Contents of the pack and other information
Lixiana contains the active substance edoxaban and belongs to a group of medicines called anticoagulants. This medicine helps to prevent blood clots from forming. It works by blocking the activity of factor Xa, which is an important component of blood clotting.
Lixiana is used in adults to:
if you are allergic to edoxaban or any of the other ingredients of this medicine (listed in section 6);
if you are actively bleeding;
if you have a disease or condition that increases the risk of serious bleeding (e.g. stomach ulcer, injury or bleeding in the brain, or recent surgery of the brain or eyes);
if you are taking other medicines to prevent blood clotting (e.g. warfarin, dabigatran, rivaroxaban, apixaban or heparin), except when changing anticoagulant treatment or while getting heparin through a venous or arterial line to keep it open;
if you have a liver disease which leads to an increased risk of bleeding;
if you have uncontrolled high blood pressure;
if you are pregnant or breast feeding.
Talk to your doctor or pharmacist before taking Lixiana,
if you have an increased risk of bleeding, as could be the case if you have any of the following conditions:
endstage kidney disease or if you are on dialysis;
severe liver disease;
bleeding disorders;
a problem with the blood vessels in the back of your eyes (retinopathy);
recent bleeding in your brain (intracranial or intracerebral bleeding);
problems with the blood vessels in your brain or spinal column;
if you have a mechanical heart valve.
Lixiana 15 mg is only to be used when changing from Lixiana 30 mg to a vitamin K antagonist (e.g. warfarin) (see section 3. How to take Lixiana).
Take special care with Lixiana,
if you know that you have a disease called antiphospholipid syndrome (a disorder of the immune system that causes an increased risk for blood clots), tell your doctor who will decide if the treatment may need to be changed.
If you need to have an operation,
it is very important to take Lixiana before and after the operation exactly at the times you have been told by your doctor. If possible, Lixiana should be stopped at least 24 hours before an operation. Your doctor will determine when to restart Lixiana.
In emergency situations your physician will help determine the appropriate actions regarding Lixiana.
Lixiana is not recommended in children and adolescents under 18 years of age. There is no information on its use in children and adolescents.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
If you are taking any of the following:
some medicines for fungal infections (e.g. ketoconazole);
medicines to treat abnormal heart beat (e.g. dronedarone, quinidine, verapamil);
other medicines to reduce blood clotting (e.g. heparin, clopidogrel or vitamin K antagonists such as warfarin, acenocoumarol, phenprocoumon or dabigatran, rivaroxaban, apixaban);
antibiotic medicines (e.g. erythromycin);
medicines to prevent organ rejection after transplantation (e.g. ciclosporin);
anti-inflammatory and pain-relieving medicines (e.g. naproxen or acetylsalicylic acid);
antidepressant medicines called selective serotonin reuptake inhibitors or serotonin- norepinephrine reuptake inhibitors;
If you are taking any of the following:
some medicines for treatment of epilepsy (e.g. phenytoin, carbamazepine, phenobarbital);
St John’s Wort, a herbal product used for anxiety and mild depression;
rifampicin, an antibiotic medicine.
Do not take Lixiana if you are pregnant or breast-feeding. If there is a chance that you could become pregnant, use a reliable contraceptive while you are taking Lixiana. If you become pregnant while you are taking Lixiana, immediately tell your doctor, who will decide how you should be treated.
Lixiana has no or negligible effects on your ability to drive or use machines.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is one 60 mg tablet once daily.
Swallow the tablet, preferably with water. Lixiana can be taken with or without food.
If you have difficulty swallowing the tablet whole, talk to your doctor about other ways to take Lixiana. The tablet may be crushed and mixed with water or apple puree immediately before you take it. If necessary, your doctor may also give you the crushed Lixiana tablet through a stomach tube.
Changing from vitamin K antagonists (e.g. warfarin) to Lixiana
Stop taking the vitamin K antagonist (e.g. warfarin). Your doctor will need to do blood measurements and will instruct you when to start taking Lixiana.
Changing from non-VKA oral anticoagulants (dabigatran, rivaroxaban, or apixaban) to Lixiana
Stop taking the previous medicines (e.g. dabigatran, rivaroxaban, or apixaban) and start Lixiana at the time of the next scheduled dose.
Changing from parenteral anticoagulants (e.g. heparin) to Lixiana
Stop taking the anticoagulant (e.g. heparin) and start Lixiana at the time of the next scheduled anticoagulant dose.
Changing from Lixiana to vitamin K antagonists (e.g. warfarin)
If you currently take 60 mg Lixiana:
Your doctor will tell you to reduce your dose of Lixiana to a 30 mg tablet once daily and to take it together with a vitamin K antagonist (e.g. warfarin). Your doctor will need to do blood measurements and will instruct you when to stop taking Lixiana.
If you currently take 30 mg (dose reduced) Lixiana:
Your doctor will tell you to reduce your dose of Lixiana to a 15 mg tablet once daily and to take it together with a vitamin K antagonist (e.g. warfarin). Your doctor will need to do blood measurements and will instruct you when to stop taking Lixiana.
Changing from Lixiana to non-VKA oral anticoagulants (dabigatran, rivaroxaban, or apixaban)
Stop taking Lixiana and start the non-VKA anticoagulant (e.g. dabigatran, rivaroxaban, or apixaban) at the time of the next scheduled dose of Lixiana.
Changing from Lixiana to parenteral anticoagulants (e.g. heparin)
Stop taking Lixiana and start the parenteral anticoagulant (e.g. heparin) at the time of the next scheduled dose of Lixiana.
If your abnormal heartbeat needs to be restored to normal by a procedure called cardioversion, take Lixiana at the times your doctor tells you to prevent blood clots in the brain and other blood vessels in your body.
Tell your doctor immediately if you have taken too many Lixiana tablets.
If you take more Lixiana than recommended, you may have an increased risk of bleeding.
You should take the tablet immediately and then continue the following day with the once daily tablet as usual. Do not take a double dose on the same day to make up for a forgotten dose.
Do not stop taking Lixiana without talking to your doctor first, because Lixiana treats and prevents serious conditions.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Like other similar medicines (medicines to reduce blood clotting), Lixiana may cause bleeding which may potentially be life-threatening. In some cases the bleeding may not be obvious.
If you experience any bleeding event that does not stop by itself or if you experience signs of excessive bleeding (exceptional weakness, tiredness, paleness, dizziness, headache or unexplained swelling) consult your doctor immediately.
Your doctor may decide to keep you under closer observation or change your medicine.
stomach ache;
abnormal liver blood tests;
bleeding from the skin or under the skin;
anaemia (low levels of red blood cells);
bleeding from the nose;
bleeding from the vagina;
rash;
bleeding in the bowel;
bleeding from the mouth and/or throat;
blood found in your urine;
bleeding following an injury (puncture);
bleeding in the stomach;
dizziness;
feeling sick;
headache;
itching.
bleeding in the eyes;
bleeding from a surgical wound following an operation;
blood in the spit when coughing;
bleeding in the brain;
other types of bleeding;
reduced number of platelets in your blood (which can affect clotting);
allergic reaction;
hives.
bleeding in the muscles;
bleeding in joints;
bleeding in the abdomen;
bleeding in the heart;
bleeding inside the skull;
bleeding following a surgical procedure;
allergic shock;
swelling of any part of the body due to allergic reaction.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on each blister or bottle after EXP. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is edoxaban (as tosilate). Lixiana 15 mg film-coated tablets
Each tablet contains 15 mg edoxaban (as tosilate).
Lixiana 30 mg film-coated tablets
Each tablet contains 30 mg edoxaban (as tosilate).
Lixiana 60 mg film-coated tablets
Each tablet contains 60 mg edoxaban (as tosilate).
- The other ingredients are: Lixiana 15 mg film-coated tablets
Tablet core: mannitol (E421), pregelatinised starch, crospovidone (E1202), hydroxypropyl cellulose (E463), magnesium stearate (E470b).
Film coat: hypromellose (E464), macrogol (8000), titanium dioxide (E171), talc (E553b), carnauba wax, iron oxide red (E172), iron oxide yellow (E172).
Lixiana 30 mg film-coated tablets
Tablet core: mannitol (E421), pregelatinised starch, crospovidone (E1202), hydroxypropyl cellulose (E463), magnesium stearate (E470b).
Film coat: hypromellose (E464), macrogol (8000), titanium dioxide (E171), talc (E553b), carnauba wax, iron oxide red (E172).
Lixiana 60 mg film-coated tablets
Tablet core: mannitol (E421), pregelatinised starch, crospovidone (E1202), hydroxypropyl cellulose (E463), magnesium stearate (E470b).
Film coat: hypromellose (E464), macrogol (8000), titanium dioxide (E171), talc (E553b), carnauba wax, iron oxide yellow (E172).
Lixiana 15 mg film-coated tablets are orange, round-shaped (6.7 mm diameter) and debossed with “DSC L15” on one side.
They come in blisters in cartons of 10 film-coated tablets or unit dose blisters in cartons of 10 x 1 film- coated tablets.
Lixiana 30 mg film-coated tablets are pink, round-shaped (8.5 mm diameter) and debossed with “DSC L30” on one side.
They come in blisters in cartons of 10, 14, 28, 30, 56, 60, 84, 90, 98 or 100 film-coated tablets or unit
dose blisters in cartons of 10 x 1, 50 x 1, or 100 x 1 film-coated tablets, or in bottles of 90 film-coated tablets.
Lixiana 60 mg film-coated tablets are yellow, round-shaped (10.5 mm diameter) and debossed with “DSC L60” on one side.
They come in blisters in cartons of 10, 14, 28, 30, 56, 60, 84, 90, 98 or 100 film-coated tablets or unit
dose blisters in cartons of 10 x 1, 50 x 1, or 100 x 1 film-coated tablets, or in bottles of 90 film-coated tablets.
Not all pack sizes may be marketed.
81379 Munich Germany
Daiichi Sankyo Europe GmbH Luitpoldstrasse 1
85276 Pfaffenhofen Germany
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
Daiichi Sankyo Belgium N.V.-S.A Tél/Tel: +32-(0) 2 227 18 80
Daiichi Sankyo Europe GmbH Tel: +49-(0) 89 7808 0
Organon Czech Republic s.r.o. Tel: +420 233 010 300
Organon Denmark ApS Tlf: +45 4484 6800
Daiichi Sankyo Deutschland GmbH Tel. +49-(0) 89 7808 0
Servier Laboratories OÜ Tel: +372 664 5040
Daiichi Sankyo Europe GmbH Τηλ: +49-(0) 89 7808 0
Daiichi Sankyo España, S.A. Tel: +34 91 539 99 11
Daiichi Sankyo France S.A.S. Tél: +33-(0) 1 55 62 14 60
Daiichi Sankyo Europe GmbH Tel: +49-(0) 89 7808 0
Daiichi Sankyo Ireland Ltd Tel: +353-(0) 1 489 3000
Vistor hf.
Sími: +354 535 7000
Daiichi Sankyo Italia S.p.A. Tel: +39-06 85 2551
Daiichi Sankyo Europe GmbH Τηλ: +49-(0) 89 7808 0
SIA Servier Latvia Tel: +371 67502039
UAB “SERVIER PHARMA” Tel: +370 (5) 2 63 86 28
Daiichi Sankyo Belgium N.V.-S.A Tél/Tel: +32-(0) 2 227 18 80
Daiichi Sankyo Europe GmbH Tel: +49-(0) 89 7808 0
Daiichi Sankyo Nederland B.V. Tel: +31-(0) 20 4 07 20 72
Organon Norway AS Tlf: +47 24 14 56 60
Daiichi Sankyo Austria GmbH Tel: +43-(0) 1 485 86 42 0
Daiichi Sankyo Europe GmbH Tel: +49-(0) 89 7808 0
Daiichi Sankyo Portugal, Unip. LDA Tel: +351 21 4232010
Daiichi Sankyo Europe GmbH Tel: +49-(0) 89 7808 0
Daiichi Sankyo Europe GmbH Tel: +49-(0) 89 7808 0
Organon Finland Oy
Puh/Tel: +358 (0) 29 170 3520
Organon Sweden AB Tel: +46 8 502 597 00
Daiichi Sankyo Europe GmbH Tel: +49-(0) 89 7808 0
QR code to be included